未治疗高血压增加开角型青光眼风险
这项回顾性观察性队列研究纳入360,330名≥40岁未服用降压或抗青光眼药物的受试者,按未治疗血压分为正常血压、血压升高、1期高血压和2期高血压组,随访平均11.76±1.37年。以正常血压为参照,1期高血压(HR 1.101,95%CI 1.050-1.155)和2期高血压(HR 1.114,95%CI 1.060-1.170)与开角型青光眼风险升高相关,血压升高组无显著差异(HR 1.056,95%CI 0.985-1.132)。
要点
- 未治疗血压越高,开角型青光眼风险越大。
- 按2017年ACC/AHA指南定义的1期高血压是开角型青光眼的显著危险因素。
- 血压升高组(收缩压120-129且舒张压<80 mm Hg)与开角型青光眼风险无显著差异。
核心结论
- 未治疗血压升高与开角型青光眼风险增加相关,且风险随血压升高而增大。
- 按2017年ACC/AHA血压指南定义的1期高血压是开角型青光眼的显著危险因素。
研究设计与样本
- 回顾性、观察性队列研究,纳入2002年1月1日至2003年12月31日健康体检时≥40岁且未服用降压药或抗青光眼药的360,330名受试者。
- 按未治疗血压分为正常血压组(收缩压<120且舒张压<80 mm Hg,n=104,304)、血压升高组(收缩压120-129且舒张压<80 mm Hg,n=33,139)、1期高血压组(收缩压130-139或舒张压80-89 mm Hg,n=122,534)和2期高血压组(收缩压≥140或舒张压≥90 mm Hg,n=100,353)。
- 采用Cox回归分析计算开角型青光眼的风险比(HR)。
主要发现
- 受试者平均年龄51.17±8.97岁,男性占56.2%。
- 平均随访11.76±1.37年期间,12,841名受试者(3.56%)被诊断为开角型青光眼。
- 以正常血压为参照,血压升高组发生开角型青光眼的多变量校正HR为1.056(95%CI 0.985-1.132)。
- 以正常血压为参照,1期高血压组发生开角型青光眼的多变量校正HR为1.101(95%CI 1.050-1.155)。
- 以正常血压为参照,2期高血压组发生开角型青光眼的多变量校正HR为1.114(95%CI 1.060-1.170)。
关键数值与推荐
- 2017年ACC/AHA血压指南定义的1期高血压为收缩压130-139或舒张压80-89 mm Hg。
- 2017年ACC/AHA血压指南定义的2期高血压为收缩压≥140或舒张压≥90 mm Hg。
- 血压升高定义为收缩压120-129且舒张压<80 mm Hg。
- 正常血压定义为收缩压<120且舒张压<80 mm Hg。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hypertension (HTN) has been associated with open-angle glaucoma (OAG), but whether elevated blood pressure (BP) alone is associated with OAG is unknown. Whether stage 1 hypertension, as per the 2017 American College of Cardiology/American Heart Association (ACC/AHA) BP guidelines, increases the risk of the disease is uncertain. DESIGN: Retrospective, observational, cohort study. METHODS: A total of 360,330 subjects who were ≥40 years of age and not taking antihypertensive or antiglaucoma drugs at the time of health examinations between January 1, 2002, and December 31, 2003, were included. Subjects were categorized based on their untreated BP, into normal BP (systolic BP [SBP] <120 and diastolic BP [DBP] <80 mm Hg; n = 104,304), elevated BP (SBP 120-129 and DBP <80 mm Hg; n = 33,139), stage 1 HTN (SBP 130-139 or DBP 80-89 mm Hg; n = 122,534), or stage 2 HTN (SBP ≥140 or DBP ≥90mm Hg; n = 100,353). Cox regression analysis was performed to calculate hazard ratios (HR) of OAG risk. RESULTS: The mean age of the subjects was 51.17 ± 8.97 years, and 56.2% were male. During a mean follow-up period of 11.76 ± 1.37 years, 12,841 subjects (3.56%) were diagnosed with OAG. Multivariable-adjusted HRs (95% CIs) were 1.056 (0.985-1.132) for elevated BP, 1.101(1.050-1.155) for stage 1 HTN, and 1.114(1.060-1.170) for stage 2 HTN with normal BP as the reference. CONCLUSIONS: The risk for OAG becomes greater with increases in untreated BP. Stage 1 HTN per the 2017 ACC/AHA BP guidelines is a significant risk factor for OAG.
引用
- Lee JS, Kim YJ, Kim S, et al. Increased Risks of Open-Angle Glaucoma in Untreated Hypertension. Am J Ophthalmol. 2023. PMID: 37030496. doi:10.1016/j.ajo.2023.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。